Societies

The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Photo from Paola Alberti/LinkedIn

Jun 30, 2024, 12:25

The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Paola Alberti, Assistant Professor of Human Anatomy at the University of Milano-Bicocca, shared on LinkedIn:

“Yesterday I had the honour to be part of a workshop dedicated to dissect the role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity (CIPN), during the 2024 The Multinational Association of Supportive Care in Cancer (MASCC) meeting in Lille, France.

I had the opportunity to discuss this fascinating topic with great experts. This first step will lead to many more efforts of a multidisciplinary group to push forward the use of biomarkers in CIPN.

I am mostly grateful to Professor Ellen Smith for inviting me and to all the incredibly knowledgeable colleagues I had the opportunity to work with!”

Source: Paola Alberti/LinkedIn

biomarkers cancer Chemotherapy-Induced Peripheral Neurotoxicity Ellen Smith MASCC24 OncoDaily Oncology Paola Alberti The Multinational Association of Supportive Care in Cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage